CORTESI, PAOLO ANGELO

CORTESI, PAOLO ANGELO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 243 (tempo di esecuzione: 0.051 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Anti-seizure medications in patients with post-stroke epilepsy: A survival analysis study 01 - Articolo su rivista 2026 Fornari, CarlaBuongarzone, GabrieleFerrara, PietroCrotti, GiacomoCortesi, Paolo AngeloRozza, DavideMantovani, Lorenzo GiovanniMazzaglia, Giampiero +
Changes in youth public psychiatric service utilization during the COVID-19 pandemic in Italy: an observational study 01 - Articolo su rivista 2026 Fornari C.Zamparini M.Crotti G.Ferrara P.Piraino A. M.Cortesi P. A.Losa L.Mazzaglia G.Mantovani L. G. +
Cost-effectiveness analysis (CEA) of ovarian cancer preventive strategies for women with BRCA1/2 pathogenic variants: the role of surveillance 01 - Articolo su rivista 2026 Negri S.Fornari C.Ye L.Inzoli A.Costa C.Mantovani L. G.Fruscio R.Cortesi P. A.
Cost-effectiveness of fenfluramine as add-on treatment in the management of Dravet Syndrome: A real-world multicenter study 01 - Articolo su rivista 2026 Cortesi P. A.Fornari C.Facchetti R.Mantovani L. G. +
Decision tree model to assess consequences and costs associated with therapy administration pathways for patients with HER2+ breast cancer in Italian oncological centers 01 - Articolo su rivista 2026 Fornari C.Mantovani L. G.Cortesi P. A. +
Economic Implication of Targeting Higher Trough Level with Extended Half-Life FVIII Prophylaxis 01 - Articolo su rivista 2026 Fornari, CarlaMantovani, Lorenzo GiovanniCortesi, Paolo Angelo +
Epidemiological and socio-economic burden of MASH (previously known as NASH) in Europe: a systematic literature review 01 - Articolo su rivista 2026 Perseghin G.Fagiuoli S.Mantovani L. G.Cortesi P. A. +
From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switching 01 - Articolo su rivista 2026 Cortesi P. A.Zambelli A. +
Hepatitis B Immunoglobulins Withdrawal in Hepatitis B Virus Mono-Infected Liver Transplant Recipients: An Italian Multicentre Prospective Study 01 - Articolo su rivista 2026 Conti S.Cortesi P. A.Carbone M.Fagiuoli S.Belli L. S. +
Il carico di malattia in Italia, dal 1990 al 2023: un’analisi regionale dal Global Burden of Disease Study 2023 01 - Articolo su rivista 2026 Conti S.Cortesi P. A.Ferrara P.Fornari C. +
Impact of Non-Anesthesiologist-Administered Propofol Sedation for Outpatient Endoscopy in the Healthcare System 01 - Articolo su rivista 2026 Mantovani L. G.Cortesi P. A. +
The social and healthcare burden of major depressive disorder in adults: an Italian observational cohort study 01 - Articolo su rivista 2026 Cortesi, Paolo AngeloCozzolino, PaoloPiraino, Maria AlexandraCrotti, GiacomoCesana, GiancarloMantovani, Lorenzo Giovanni +
Towards a value-based approach in hemophilia: indications from the FAR-BENE study 01 - Articolo su rivista 2026 Cortesi P. A.
Use of Aflibercept 8 mg for the Treatment of Diabetic Macular Edema in Italy: A Cost-Minimisation Analysis Based on an Indirect Treatment Comparison 01 - Articolo su rivista 2026 Cortesi P. A. +
A COST PER RESPONDER ANALYSIS OF LIPID-LOWERING THERAPIES IN PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN ITALY 01 - Articolo su rivista 2025 Cortesi, PAMantovani, LG +
Budget Impact Analysis of Lebrikizumab for Treating Severe Atopic Dermatitis 01 - Articolo su rivista 2025 Mantovani L. G.Cortesi P. A. +
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 01 - Articolo su rivista 2025 Belingheri, MichaelConti, SaraCortesi, Paolo AngeloFerrara, PietroFornari, CarlaLa Vecchia, AdrianoMantovani, Lorenzo Giovanni +
BURDEN OF DUCHENNE MUSCULAR DYSTROPHY IN ITALY: A MULTICENTER COST OF ILLNESS STUDY 01 - Articolo su rivista 2025 Fornari, CCozzolino, PMantovani, LGCortesi, PA +
Cost-Consequence Analysis of Natalizumab Compared with Other High-Efficacy Treatments in Patients with Relapsing–Remitting Multiple Sclerosis 01 - Articolo su rivista 2025 Fornari C.Cortesi P. A. +
Cost-effectiveness analysis of treatment with TTFields in combination with temozolomide compared to temozolomide alone in subjects with grade 4 glioma in Italy 01 - Articolo su rivista 2025 Cortesi, PAFerrara, PLosa, LMantovani, LG +